Randy Burd, Ph.D. is the Associate Vice President for Global Research Alliances in the office of Research, Discovery and Innovation. He also serves as the Assistant Director of Distance and Global Initiatives in the College of Agriculture and Life Sciences, where he holds a faculty appointment as a Professor of Nutritional Sciences. His role in these linked positions is to lead the expansion of programs and initiatives to increase global research and connect faculty to new international research opportunities. He also has extensive expertise in technology, innovation and distance education, and in developing international research and academic programs.
Dr. Burd received his Ph.D. in Molecular and Cellular Biophysics in 1998 from the Roswell Park Cancer Institute in Buffalo, New York. In 2002 he was appointed the director of Pre-Clinical Therapeutics at Thomas Jefferson University. In 2005 he was recruited to the University of Arizona to establish a Nutrigenomics program to identify new bioactive food compounds that could be developed into pharmaceuticals. In 2012 he assumed the role of Assistant Vice President for Program Innovation, and now serves as Associate Vice President for Research, Global Research Alliances. His current research efforts focus on bioactive food compounds and he also publishes in the areas of technology and innovation. He currently teaches a course in Nutrigenomics. His research and education programs have been funded through various sources including international, federal, state, foundation and industrial.
Current research interests in our laboratory focus on improving tumor radiation response through the use of biological response modifiers that alter tumor cell function, metabolism, cytokine stimulation and prostaglandin production, and affect aspects of tumor development, growth and treatment response. These include pharmaceutical drugs that are designed to specifically target tumors, bioactive nutritional components such as bioflavonoids, and compounds that regulate tumor glucose metabolism.
- Mars MM and Burd R. Impact over Profits: Toward a Social Entrepreneurship Model for University Technology Transfer. J Entrepreneurship & Organization Mgmt. 2013, In Press.
- The promise of digital (mobile) health in cancer prevention and treatment. Panayi ND, Mars MM, Burd R. Future Oncol 2013;9(5):613-7.
- Collection and visualization of dietary behavior and reasons for eating using twitter. Hingle M, Yoon D, Fowler J, Kobourov S, Schneider ML, Falk D, Burd R. J Med Internet Res 2013;24;15(6):e125.
- Mendoza EE, Pocceschi M, Kong X, Caro J, Limesand KH, Leeper DB, Burd R. Control of Glycolytic Flux by AMP-Activated Protein Kinase in Tumor Cells Adapted to Low pH, Translational Oncology, 2012;5(3):208-216.
- Martin KL, Hill GA, Klein RR, Arnett DG, Burd R, Limesand KH. Prevention of radiation-induced salivary gland dysfunction utilizing a CDK inhibitor in a mouse model PLoS One 2012;7(12).
- Mendoza EE, Burd R. Quercetin as a systemic chemopreventative agent: structural and functional mechanisms. Mini Rev Med Chem. 2011 Dec 1;11(14):1216-21.
- Mitchell GC, Fillinger JL, Sittadjody S, Avila JL, Burd R, Limesand KH. IGF1 activates cell cycle arrest following irradiation by reducing binding of ΔNp63 to the p21 promoter. Cell Death Dis. 2010;1:e50.
- Vargas AJ, Sittadjody S, Thangasamy T, Mendoza EE, Limesand KH, Burd R. Exploiting tyrosinase expression and activity in melanocytic tumors: quercetin and the central role of p53. Integr Cancer Ther. 2011 Dec;10(4):328-40. Epub 2010 Dec 31.
- Victory K, Burd R, Fribley A, Sittadjody S, Arnett D, Klein RR, Limesand KH. Head and neck tumor cell radiation response occurs in the presence of IGF1. J Dent Res. 2011 Mar;90(3):347-52.
- Mitchell G, Fillinger J, Sittadjody S, Avila J, Burd R, Limesand K. IGF1 activates cell cycle arrest following irradiation by reducing binding of ΔNp63 to the p21 promoter. Cell Death Dis. 2010 Jun 10;2010(1):e50.
- Grundmann O, Fillinger JL, Victory KR, Burd R, Limesand KH. Restoration of radiation therapy-induced salivary gland dysfunction by post therapy IGF-1 administration. BMC Cancer. 2010 Aug 10;10:417.
- Vargas AJ, Burd R. Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management. Nutr Rev. 2010 Jul;68(7):418-28.
- Thangasamy T, Sittadjody S, Mitchell GC, Mendoza EE, Radhakrishnan VM, Limesand KH, Burd R. Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73. BMC Cancer. 2010 Jun 11;10:282.
2015-2016 Visiting Professor, Universidad de las Américas Puebla, Puebla, MX
2012-Present Assistant Vice President for Program Innovation, Global Initiatives, UA
2012-Present Assistant Director, Global Initiatives, UA College of Agriculture and Life Sciences
2011-Present Associate Professor with Tenure, Department of Nutritional Sciences, UA
2005-2011 Assistant Professor, Department of Nutritional Sciences, The University of Arizona (UA)
2003-2005 Director, Pre-clinical Therapeutics, Department of Radiation Oncology, Thomas Jefferson U.
2002-2005 Assistant Professor, Department of Radiation Oncology, Thomas Jefferson University.
2005-2014 Adjunct Faculty, Department of Radiologic Sciences, Holy Family College
2004-Present Adjunct Assistant Professor, Department of Radiation Oncology, Thomas Jefferson U.
2004-2012 Adjunct Faculty, Department of Radiological Sciences, Thomas Jefferson University
2001-2015 Associated Faculty, School of Radiation Therapy, Cooper Health System, NJ
2014 International Faculty Lecturer, Universidad Estatal de Sonora, Hermosillo, MX
2012 Fellow, Bart Cardon Teaching Academy, The University of Arizona, Tucson, AZ
2012 Fellow, Academic Leadership Institute, The University of Arizona, Tucson, AZ
2011 Research Career Development Award, College of Agriculture & Life Sciences, University of Arizona, Tucson, AZ
2009 Bart Cardon Early Career Faculty Teaching Award, College of Agriculture & Life Sciences, University of Arizona, Tucson, AZ
2008 Lamda nu Lecturer, Radiation Biology Honor Society, Holy Family College, Philadelphia, PA
2004 Young Alumnus Achievement Award, University College at Buffalo, Buffalo, NY
2004 David Vernon Bullough Award for Academic Excellence in Biology, University College at Buffalo, Buffalo, NY
1994 Cum Laude, University College at Buffalo, Buffalo, NY
2014-Present Nutrition and Cancer, Editorial Board
2012-Present Journal of Food and Nutritional Disorders, Founding Editorial Board
2010-2014 Nutrition and Cancer, Associate Editor
2014 Partners of the Americas 100K Strong Round Five
2012 Defense Threat Reduction Agency, Production of Reactive Oxygen Species in Cancer Stem Cells Subsequent to Acute Radiation Exposure, Scientific Reviewer
2011 USDA Higher Education Challenge Review Panel, Scientific Reviewer
2010 Department of Defense, BCRP Clinical & Experimental Therapeutics #1, Scientist Reviewer
2009 Department of Defense, BCRP Concept-Cell Biology #2, Online Reviewer
2008 Department of Defense, Breast Cancer Research Program (BCRP) Clinical & Experimental Therapeutics #1, Scientist Reviewer